MedElevator
Войти в исследования Journal of the neurological sciences · 2025
Diagnosing progressive multifocal leukoencephalopathy: Positive predictive value of CSF JC virus quantitative PCR and importance of recognizing suggestive neuroimaging findings.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhou Ryan, Sangam Kamala, Cabrera Ana, AlMutawa Fatimah, Sivro Aida, Roy Felicia, Silverman Michael, Sharma Manas, Budhram Adrian
Аннотация
OBJECTIVE: To determine the positive predictive value (PPV) of CSF John Cunningham virus (JCV) quantitative PCR (qPCR) for progressive multifocal leukoencephalopathy (PML), and highlight neuroimaging findings reported to be suggestive of this disease.
METHODS: We reviewed patients at London Health Sciences Centre with a positive CSF JCV qPCR result. Patients were classified as true-positive if they had a clinico-radiographic presentation compatible with PML and no more likely alternative diagnosis. The presence of suggestive neuroimaging findings was documented as supportive evidence of PML. The PPV of CSF JCV qPCR was calculated as the proportion of positive results that were classified as true-positives.
RESULTS: Eleven of 154 patients who underwent CSF JCV qPCR testing had a positive result (7 %). Median age was 60 years (range: 33-79 years) and 7/11 (64 %) were male. Nine of 11 (82 %) were overtly immunocompromised. Five of 11 (45 %) had a viral load below the lowest quantifiable standard (<4290 copies/ml). All had a clinico-radiographic presentation compatible with PML and no more likely alternative diagnosis, resulting in a PPV of 100 %. All had one or more suggestive neuroimaging findings that supported PML diagnosis (Milky Way sign/punctate pattern, 9; rim-and-core pattern, 7; T2/FLAIR mismatch, 6; shrimp sign, 4; SWI-hypointense rim, 2; across-the-pons sign, 1; barbell sign, 1).
CONCLUSIONS: We found that CSF JCV qPCR had high PPV for PML. All positives below the lowest quantifiable standard were true-positives. Our study affirms the diagnostic utility of this testing in clinical practice. Recognition of suggestive neuroimaging findings helps facilitate PML diagnosis.
METHODS: We reviewed patients at London Health Sciences Centre with a positive CSF JCV qPCR result. Patients were classified as true-positive if they had a clinico-radiographic presentation compatible with PML and no more likely alternative diagnosis. The presence of suggestive neuroimaging findings was documented as supportive evidence of PML. The PPV of CSF JCV qPCR was calculated as the proportion of positive results that were classified as true-positives.
RESULTS: Eleven of 154 patients who underwent CSF JCV qPCR testing had a positive result (7 %). Median age was 60 years (range: 33-79 years) and 7/11 (64 %) were male. Nine of 11 (82 %) were overtly immunocompromised. Five of 11 (45 %) had a viral load below the lowest quantifiable standard (<4290 copies/ml). All had a clinico-radiographic presentation compatible with PML and no more likely alternative diagnosis, resulting in a PPV of 100 %. All had one or more suggestive neuroimaging findings that supported PML diagnosis (Milky Way sign/punctate pattern, 9; rim-and-core pattern, 7; T2/FLAIR mismatch, 6; shrimp sign, 4; SWI-hypointense rim, 2; across-the-pons sign, 1; barbell sign, 1).
CONCLUSIONS: We found that CSF JCV qPCR had high PPV for PML. All positives below the lowest quantifiable standard were true-positives. Our study affirms the diagnostic utility of this testing in clinical practice. Recognition of suggestive neuroimaging findings helps facilitate PML diagnosis.